global
Variables
Utilities
CUSTOM STYLES

GO2 for Lung Cancer and Patient Data Vault Partner to Expand Clinical Trial Navigation Access for Lung Cancer Patients

Collaboration brings Patient Data Vault’s AI-powered trial matching to GO2’s LungMATCH program and gives patients on both platforms more expert support

GO2 for Lung Cancer and Patient Data Vault (PDV) today announced a pilot collaboration to help people living with lung cancer identify clinical trials that may fit their diagnosis and circumstances, and to make sure they have expert support in deciding what to do next.

Identifying appropriate clinical trials can be challenging. Trial eligibility often depends on complex clinical and biomarker information, and options may change as studies open, close, or modify enrollment criteria. Additionally, most patients and caregivers are doing this research on their own, often under time pressure. Through LungMATCH, GO2 for Lung Cancer helps patients identify and evaluate clinical trial opportunities with support from specialized navigators. Patient Data Vault complements that work through a technology platform that analyzes patient-authorized medical records and matches them to relevant open clinical trials. Through the pilot, the two organizations are connecting those capabilities so patients have more support at every step:

  • LungMATCH users may choose to upload medical records to PDV's trial-matching platform to receive a personalized report of potential clinical trial options, then connect with a navigator from either or both organizations.
  • PDV users living with lung cancer will be connected to GO2's LungMATCH navigators and comprehensive patient support services for guidance that extends beyond clinical trial matching, including biomarker result interpretation and understanding FDA-approved treatment options.
  • PDV's lung cancer report will include access to GO2's trusted library of peer-reviewed, patient- friendly educational resources.
  • When a patient chooses to share their trial matches, LungMATCH navigators can review them with the patient in PDV’s navigator platform.
  • PDV's own care navigators are also available to walk patients through their results.

Patients remain in control of their information throughout the process. Medical records are not sold, licensed, or shared without the patient's explicit authorization, and patients determine what information, if any, is shared between the organizations.

“GO2’s mission is to relentlessly confront lung cancer on every front, every day, for everyone. That includes helping people access and understand the information that shapes their care. Our collaboration with Patient Data Vault reflects a shared commitment to empowering patients with information as they explore treatment and clinical trial options. Through GO2’s LungMATCH program, our navigators provide personalized, independent guidance to help patients and families make informed decisions and take the next steps in their care,” said Dave Benson, CEO of GO2 for Lung Cancer.

“When my mother was diagnosed with lung cancer, I spent months doing exactly what thousands of families do every week: reading trial listings at night, trying to understand which ones might apply to her, and hoping I was not missing something. We built PDV so no family has to do that alone,” said Max Doppelt, Founder and CEO of Patient Data Vault. “Patients deserve both the research and the people. Our navigators do that work every day, and GO2’s navigators have been doing it for the lung cancer community for years. Putting those together means a patient has more experts in their corner, and gets to them faster.”

The pilot begins November 16th, 2026.